Atrial Tachycardia
Atrial tachycardia (AT) is defined as a supraventricular arrhythmia originating from the atrial tissue outside of the sinus node, typically presenting with a heart rate between 100 and 250 bpm. Atrial tachycardia is independent of sinus node activity.1 2
Atrial tachycardia is an uncommon type of supraventricular tachycardia and can be either paroxysmal or sustained, depending on its duration and clinical characteristics.3 4
There are several types of atrial tachycardia, which are differentiated primarily by their electrophysiological mechanisms and clinical presentations. The most relevant types are:
- Focal atrial tachycardia.
- Multifocal atrial tachycardia.
- Sinus node reentrant tachycardia.
Focal Atrial Tachycardia
Focal atrial tachycardia (FAT) is defined as an atrial supraventricular tachycardia with a heart rate greater than 100 bpm, arising from a discrete origin and propagating throughout both atria in a centrifugal pattern.3 4
The ventricular rate varies depending on atrioventricular nodal conduction and is typically characterized by a regular rhythm. However, irregularity may occasionally be observed, particularly during onset ("warm-up" phenomenon) and termination ("cool-down" phenomenon).3 4
Symptoms may include palpitations, dyspnea, chest pain, and, in rare instances, syncope or presyncope. The arrhythmia can be sustained or incessant.4
Dynamic forms featuring recurrent interruptions and resets (reinitiations) are frequently observed.4
Focal Atrial Tachycardia:
A regular, narrow-QRS tachycardia at 120 bpm with negative P waves in the inferior and precordial leads.
The identification of the P wave on a 12-lead electrocardiogram (EKG) during tachycardia is critical
Depending on AV conduction and the heart rate, P waves may be concealed within the QRS complexes or T waves.4
Electrocardiographic Findings in Focal Atrial Tachycardia
According to Chou's Electrocardiography in Clinical Practice,1 the electrocardiographic criteria for focal atrial tachycardia are as follows:1
- 1. Presence of three or more consecutive abnormal P waves with a morphology distinctly different from that of sinus P waves.
- 2. The atrial rate is typically between 100 and 180 bpm.
- 3. The rhythm is regular (following the initial complexes).
- 4. The paroxysm consists of three or more consecutive complexes.
- 5. A QRS complex follows each P wave; the QRS complex usually resembles that of the sinus complex unless aberrant ventricular conduction is present.
- 6. The PR interval is typically normal or prolonged.
- 7. Tachycardia-induced ST-segment and T-wave changes may occur.1
Adenosine administration can aid in diagnosis by slowing the ventricular rate or, less frequently, by terminating the focal atrial tachycardia.4
A discrete P wave with an intervening isoelectric interval strongly suggests a focal atrial tachycardia. However, it is not always possible to definitively distinguish focal from macroreentrant arrhythmias on a surface EKG.4
The duration of individual episodes can assist in differentiation; reentrant tachycardias tend to be more sustained than episodes of atrial tachycardia, which may present as a series of repetitive runs.4
Focal tachycardias typically exhibit a gradual acceleration ("warm-up" phenomenon) at onset, followed by a deceleration period ("cool-down" phenomenon) prior to termination.2 4
In the adult population, focal atrial tachycardia is generally associated with a benign prognosis, although atrial tachycardia-mediated cardiomyopathy has been reported in up to 10% of patients. Non-sustained focal atrial tachycardia is common and frequently requires no intervention.3
Multifocal Atrial Tachycardia
Multifocal atrial tachycardia (MAT) is defined as a rapid, irregular rhythm characterized by at least three distinct P-wave morphologies on the surface EKG.4
Multifocal atrial tachycardia is commonly associated with underlying comorbidities, such as pulmonary disease, pulmonary hypertension, coronary artery disease, and valvular heart disease, as well as hypomagnesemia and theophylline therapy.4
It may also be observed in healthy infants under 1 year of age, carrying an excellent prognosis in the absence of structural heart disease.4
Multifocal Atrial Tachycardia:
An irregular tachycardia at 125 bpm with ectopic P waves (negative in lead II).
Differentiating multifocal atrial tachycardia from atrial fibrillation on a surface ECG can be challenging; therefore, a 12-lead ECG is indicated to confirm the diagnosise.4
On the electrocardiogram, the atrial rate exceeds 100 bpm and, distinct from atrial fibrillation, a well-defined isoelectric period is present between visible P waves.
The P-P, P-R, and R-R intervals are inherently variable. Although variability in P-wave morphology implies a multifocal origin, very few mapping studies of multifocal atrial tachycardia have been performed.4
First-line treatment involves management of the underlying condition. Intravenous magnesium may also be beneficial in patients with normal baseline magnesium levels.3
Antiarrhythmic drugs are generally ineffective in suppressing multifocal atrial tachycardia..3
Electrical cardioversion is typically not effective for multifocal atrial tachycardia.3
Sinus Node Reentrant Tachycardia
Sinus node reentrant tachycardia is an uncommon type of focal atrial tachycardia generated by a microreentrant circuit within the sinoatrial nodal region. This produces a P-wave morphology identical to that of sinus tachycardia, despite not being a true sinus tachycardia.3
The features that distinguish sinus node reentry from sinus tachycardia and inappropriate sinus tachycardia are its paroxysmal nature—demonstrating abrupt onset and termination—and frequently a longer RP interval than that observed during normal sinus rhythm.3 4
On the electrocardiogram, the polarity and configuration of the P waves are similar to those of sinus P waves.3 4
Diagnosis of Sinus Node Reentrant Tachycardia3>
Sinus node reentrant tachycardia is suspected based on surface ECG and Holter monitoring. Diagnosis can be definitively confirmed via an electrophysiology study.4
Treatment of Sinus Node Reentrant Tachycardia
Medical therapy remains empirical; verapamil and amiodarona have demonstrated variable success, whereas beta-blockers are typically ineffective.4
Sinus node reentrant tachycardia can be safely and effectively treated via catheter ablation targeting the site of earliest atrial activation relative to the P wave.4
Atrial tachycardia is a complex arrhythmia that demands a precise diagnostic approach and individualized management.
The electrocardiogram remains the cornerstone of identification, and current guidelines provide a robust framework for its clinical management.
References
- 1. Surawicz B, Knilans TK. Chou's electrocardiography in clinical practice, 6th ed. Philadelphia: Elservier; 2008.
- 2. Roberts-Thomson KC, Kistler PM, Kalman JM. Atrial Tachycardia: Mechanisms, Diagnosis, and Management. 2005; 30(10): 529-573 doi: 10.1016/j.cpcardiol.2005.06.004.
- 3. Page RL, Joglar JA, Caldwell MA,et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Circulation. 2015; 133(14). doi: 10.1161/CIR.0000000000000310.
- 4. Brugada J, Katritsis DG, Arbelo E, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia
The Task Force for the management of patients with supraventricular tachycardia of the European Society of Cardiology (ESC): Developed in collaboration with the Association for European Paediatric and Congenital Cardiology (AEPC). Eur. Heart J. 2020; 41(5): 655–720. doi: 10.1093/eurheartj/ehz467.